Drug
SBR 759 clinical trials
Also written SBR759.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses SBR 759 is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on HemodialysisCompletedPhase 1/2Novartis PharmaceuticalsNCT00750295Written as SBR759
- Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on HemodialysisCompletedPhase 2Novartis PharmaceuticalsNCT00704483Written as SBR759
- Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on HemodialysisCompletedPhase 2Novartis PharmaceuticalsNCT00704678Written as SBR759